home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Sapphire Collection
/
Software Vault (Sapphire Collection) (Digital Impact).ISO
/
cdr16
/
med9410d.zip
/
M94A0580.TXT
< prev
next >
Wrap
Text File
|
1994-10-21
|
2KB
|
28 lines
Document 0580
DOCN M94A0580
TI Kaposi's sarcoma (K.S.): the Fairfield Hospital experience.
DT 9412
AU Padiglione A; Goldstein D; Fairfield Hospital, Vic.
SO Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:96 (poster no. 42).
Unique Identifier : AIDSLINE ASHM5/94349075
AB Kaposi's sarcoma is the most common malignancy occurring in patients
with HIV infection, affecting about 21% of patients with AIDS, and is
associated with significant morbidity and mortality. A number of
therapeutic interventions are employed in the routine management of
these patients, principally being alpha interferon, radiotherapy and
cytotoxic chemotherapy. A survival benefit for chemotherapy has not yet
been clearly demonstrated. In this study, we retrospectively analysed
the effect of chemotherapy on the natural history of K.S., by analysing
the case records of over 30 patients with K.S. treated with between 1988
and 1992, and comparing these with matched controls of patients with
untreated K.S. We also analysed the effect on survival of having K.S. as
the AIDS defining illness.
DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/MORTALITY Human
Retrospective Studies Sarcoma, Kaposi's/*DRUG THERAPY/MORTALITY Skin
Neoplasms/*DRUG THERAPY/MORTALITY Survival Analysis Victoria MEETING
ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).